Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 11

The effect of growth hormone deficiency on inflammatory markers in Sheehan's syndrome

Pages
2958–2962
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results showed that growth hormone deficiency led to a decrease insome inflammatory markers such as MPV, NLR, PLR.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Mean platelet volume (MPV), lymphocyte count (LC), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR)are currently gaining interest as new markers of inflammation and independent risk factors for cardiovascular diseases.
📊
Key Findings & Data:The aim ofthis study was to evaluate the effect of growth hormone (GH) deficiency on MPV, NLR, and PLR values in patients with Sheehan’ssyndrome.Materials and Methods: 23 women with Sheehan’s syndrome (SS), and 30 healthy women as control group were included in thestudy.
💡
Conclusion & Impact:These results showed that growth hormone deficiency led to a decrease insome inflammatory markers such as MPV, NLR, PLR.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Mean platelet volume (MPV), lymphocyte count (LC), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR)are currently gaining interest as new markers of inflammation and independent risk factors for cardiovascular diseases. The aim ofthis study was to evaluate the effect of growth hormone (GH) deficiency on MPV, NLR, and PLR values in patients with Sheehan’ssyndrome.Materials and Methods: 23 women with Sheehan’s syndrome (SS), and 30 healthy women as control group were included in thestudy. The study was performed retrospectively. Demographic and clinical characteristics, hormone and haematological parametersof subjects were evaluated. MPV, NLR, PLR and LC values were compared between two groups.Result: The mean age of SS and control groups were 53.1 ± 11.1 and 55.1 ± 10.5 years, respectively. MPV, PLR, NLR were lower andLC was higher in SS group than the control group. (p = 0.010, 0.033, 0.017, 0.010 respectively). A significant positive correlation wasfound between insulin-like growth factor1 (IGF1) and MPV, PLR in the SS group (p = 0.003 r: 0.62, p: 0.033 r: 0.46).Conclusion: MPV, NLR, PLR were lower and LC was higher in SS group compared to control group. There was a significant positivecorrelation between IGF1 and MPV, PLR in the SS group. These results showed that growth hormone deficiency led to a decrease insome inflammatory markers such as MPV, NLR, PLR. Increased LC in these patients may indicate inflammation.

🔖

Cite This Article

SAKİN, A., YILDIZ, S., ALAY, M., SÖNMEZ, G. M. (2022). The effect of growth hormone deficiency on inflammatory markers in Sheehan's syndrome. Annals of Medical Research, Cilt: 27 - Sayı: 11, 2958–2962. https://ajindex.com/articles/446248

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Kelestimur F. Sheehan's syndrome. Pituitary 2003;6:181-8
  2. Sheehan HL. Postpartum necrosis of the anterior pituitary J Pathol Bacteriol 1937;45:189-214
  3. Sheehan H.L, The frequency of post-partum hypopituitarism J Obstet Gynaecol Br Commonw 1965;72:103-11
  4. Toogood AA, Ryder WD, Beardwell CG, et al. The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status. Clin Endocrinol (Oxf) 1995;43:97-103
  5. Dizerega G, Kletzky OA, Mishell DR. Diagnosis of Sheehan's syndrome using a sequential pituitary stimulation test. J American Journal of Obstetrics Gynecology 1978;132:348-53
  6. Cook JE, Bean WB, Franklın M, et al. Postpartum necrosis of the anterior lobe of the pituitary gland: Sheehan's disease. Jama Archives of Int Med1951;87:517-32
  7. Rosén T, Bengtsson BA. Premature mortality due to cardiovascular disease inhypopituitarism. Lancet 1990;336:285-8
  8. Clayton RN. Mortality, cardiovascular events and risk factors in hypopituitarism. Growth Horm IGF Res 1998;8:69-76
  9. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482-94
  10. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010;8:148-56
  11. Martin JF, Trowbridge EA, Salmon G, et al. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443-60
  12. Valkila EH, Salenius JP, Koivula TA. Platelet indices in patients with occlusive carotid artery disease. Angiology 1994;45:361-5
  13. Avramakis G, Papadimitraki E, Papakonstandinou D, et al: Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina. Platelets 2007;18:16-23
  14. Tasoglu I, Sert D, Colak N, et al. Neutrophil lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost 2013;20:645-50
  15. Sunbul M, Gerin F, Durmus E, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens 2014;36:217-21
  16. Gunay E, Sarınc¸ Ulaslı S, et al. Neutrophiltolymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation 2014;37: 374-80
  17. McKarns SC, Smith CJ, Morton MJ, et al. Correlation of hematologic